APA (7th ed.) Citation

Diamant, M., Van Gaal, L., Stranks, S., Guerci, B., MacConell, L., Haber, H., . . . Trautmann, M. (2012). Safety and Efficacy of Once-Weekly Exenatide Compared With Insulin Glargine Titrated to Target in Patients With Type 2 Diabetes Over 84 Weeks. Diabetes Care, 35(4), 683. https://doi.org/10.2337/dc11-1233

Chicago Style (17th ed.) Citation

Diamant, Michaela, Luc Van Gaal, Stephen Stranks, Bruno Guerci, Leigh MacConell, Harry Haber, Jamie Scism-Bacon, and Michael Trautmann. "Safety and Efficacy of Once-Weekly Exenatide Compared With Insulin Glargine Titrated to Target in Patients With Type 2 Diabetes Over 84 Weeks." Diabetes Care 35, no. 4 (2012): 683. https://doi.org/10.2337/dc11-1233.

MLA (9th ed.) Citation

Diamant, Michaela, et al. "Safety and Efficacy of Once-Weekly Exenatide Compared With Insulin Glargine Titrated to Target in Patients With Type 2 Diabetes Over 84 Weeks." Diabetes Care, vol. 35, no. 4, 2012, p. 683, https://doi.org/10.2337/dc11-1233.